PFD has also been reported to attenuate bleomycin-induced pulmonary fibrosis in mice by improving the expression of Nrf2, HO-1 and GPx1 and reducing levels of ROS and MDA in serum, BALF and lung tissues (Liu et al., 2017b). The gene discussed is NFE2L2; the disease is pulmonary fibrosis.